RE:RE:RE:Improving results yetfecats wrote: Don't k know if anyone else noticed, but this is the first time there has been a mention of 2027 for full approval. Also when mentioning pre-BTD they indicate Q1 as before but they also previously said BTD in Q1 as well. This looks to me like everything is being pushed out again but they have not come right out and said it . To me it looks like it is unlikely we will be getting BTD in Q1
Hi fecats, I'm not sure if I'm correct in saying however in my understanding full approval is given at the end of the patient trial study period which means they are approved to distribute to hospitals for treatment (commercialization). Should Theralase be given AA while the trial study period is ongoing I believe this to mean they can immediately distribute to hospitals for treatment (commercialization).
If my assumptions are wrong please correct.